期刊文献+

青蒿琥酯对人淋巴细胞白血病/淋巴瘤细胞抑制作用及机理的研究 被引量:8

Inhibitive Effect of Artesunate on Human Lymphoblastic Leukemia/Lymphoma Cells
下载PDF
导出
摘要 目的观察青蒿琥酯(ART)对白血病/淋巴瘤细胞株Raji、Jurkat和急性淋巴细胞白血病(ALL)原代细胞的增殖抑制作用,以及ART与长春新碱(VCR)、阿糖胞苷(Ara-C)的细胞毒协同效应,并探讨其作用机制。方法MTT法观察ART对Raji、Jurkat、ALL原代细胞的增殖抑制效应及ART与VCR、Ara-C的协同效应。Wright-Giemsa染色光镜下及透射电镜观察细胞凋亡的形态变化,Rhodamine-123检测线粒体跨膜电位(MMP)变化,比色法检测细胞内caspase-3浓度变化。结果ART在体外能显著抑制Raji、Jurket细胞的增殖,对ALL原代细胞亦具有增殖抑制作用。低浓度ART与VCR、Ara-C联合,能增加VCR、Ara-C的细胞毒作用。ART作用后B/T淋巴细胞白血病/淋巴瘤细胞光镜及电镜均表现出凋亡形态学改变,线粒体跨膜电位下降,细胞内caspase-3的表达增加,呈浓度依赖性。与对照组相比,差异具有统计学意义(P<0.05)。结论ART对淋巴细胞白血病/淋巴瘤细胞具有抑制作用,且与VCR、Ara-C联用具有协同效应,其机制与诱导肿瘤细胞凋亡有关。ART有望开发成治疗ALL/淋巴瘤的新药。 Objective To test the effect of Artesunate(ART) on the proliferation of Raji cells,Jurkat cells and acute lymphoblastic leukemia(ALL) primary cells;to determine the synergistic antiproliferation effect between ART and Vincristine(VCR) or Cytarabine(Ara-C) on Raji and Jurkat cells;and to explore the mechanism of ART induced apoptosis of tumor cells in vitro. Methods MTT assay was performed to detect the inhibition of proliferation of Raji,Jurkat,and ALL primary cells.The cells were exposed to ART at various concentrations with or without VCR or Ara-C.The morphological changes of Raji and Jurkat cells were observed under light microscopy after Wright-Giemsa dyeing and electron transmission microscopy.The mitochondria transmenbrane potential was measured by Rhodamine 123 staining.Colorimetric method was used to measure the activities of caspase-3 in those tumor cells.Results ART inhibited the proliferation of Raji cells,Jurkat cells and ALL primary cells.The cytotoxicity of ART on Raji cells and Jurkat cells at a low concentration increased when combined with VCR or Ara-C.Apoptosis in Raji cells and Jurkat cells appeared after exposure to ART.Raji cells and Jurkat cells exposed to ART showed mitochondria transmembrane potential collapse.ART increased the caspase-3 activities of Raji,Jurkat and ALL primary cells.Conclusion ART alone or combined with chemotherapy drugs could inhibit the proliferation of B/T lymphocytic tumor cell lines as well ALL primary cells in vitro,probably through the mechanism of apoptosis,which suggest that ART is likely to be a potential drug in the treatment of leukemia /lymphoma.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2009年第6期1038-1043,共6页 Journal of Sichuan University(Medical Sciences)
关键词 青蒿琥酯 急性淋巴细胞白血病/淋巴瘤 增殖抑制 细胞凋亡 Artesunate Acute lymphoblastic leukemia/lymphoma Inhibitory proliferation Apoptosis
  • 相关文献

参考文献15

二级参考文献28

  • 1颜子颖 王海林.精编分子生物学实验指南[M].北京:科学出版社,1998.17-287. 被引量:101
  • 2屠呦呦 倪慕云 等.中药青蒿化学成分研究Ⅰ[J].药学学报,1981,16(5):366-370. 被引量:3
  • 3杨小平,潘启超,梁永钜,张以琳.青蒿酯钠的抗肿瘤作用[J].癌症,1997,16(3):186-187. 被引量:57
  • 4[1]Woerdenbag HJ, Moskal TA, Pras N, Malingre TM, el-Feraly FS, Kampinga HH, et al. Cytotoxicity of arte misinin-related endoperoxides to Ehrlich ascites tumor cells [J]. J Nat Prod,1993; 56(6): 849- 56 被引量:1
  • 5[3]Li Y, Shan F, Wu JM, Wu GS, Ding J, Xiao D, et al. Novel antitumor artemisinin derivatives targeting G1 phase of the cell cycle[J]. Bioorg Med Chem Lett, 2001;11(1):5- 8 被引量:1
  • 6[7]Singh NP, Lai H. Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells[J]. Life Sciences, 2001;70(1):49- 56 被引量:1
  • 7[8]Moore JC, Lai H, Li JR, Ren RL, McDougall JA, Singh NP,et al. Oral administration of dihydroartemisinin and ferrous sulfate retarded implanted fibrosarcoma growth in the rat[J]. Cancer Lett, 1995;98(1):83- 7 被引量:1
  • 8[9]Lai H, Singh NP. Selective cancer cell cytotoxicity from exposure to dihydroartemisinin and holotransferrin [J]. Cancer Lett,1995;91(1) :41 - 6 被引量:1
  • 9[10]Olie RA, Simoes-Wust AP, Baunann B, Leech SH, Fabbro D, Stahel RA, et al. A novel antisense oligonucleotide targeting surviving expression induces apoptosis and sensitizes lung cancer cells to chemotherapy[J]. Cancer Res, 2000; 60 (11):2805 - 9 被引量:1
  • 10[11]Shin S, Sung B J, Cho YS, Kim H J, Ha NC, Hwang JI, et al. An anti-apoptotic protein human survivin is a direct inhibitor of Caspase-3 and-7[J]. Biochenistry, 2001 ;40(4): 1117 - 23 被引量:1

共引文献77

同被引文献86

引证文献8

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部